Oxford/AstraZeneca publish peer-reviewed efficacy results—here's what they tell us and what they don't
The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy results from phase 3 trials published in a peer-reviewed journal.
Dec 10, 2020
0
6